Hydroxyzine Does Not Directly Affect Serum Sodium Levels
Hydroxyzine does not cause hyponatremia or hypernatremia and has no direct effect on serum sodium concentrations. The available evidence, including FDA drug labeling and clinical guidelines, does not identify sodium disturbances as a recognized adverse effect of hydroxyzine therapy 1.
Key Clinical Considerations
Pharmacologic Profile
Hydroxyzine is a first-generation sedating H1-antihistamine with anticholinergic properties 2, 3. Its primary effects include:
- Sedation and CNS depression
- Anticholinergic effects (dry mouth, urinary retention, constipation)
- Antihistaminic and antiemetic properties
- Mild antisecretory activity without increasing gastric acidity 1
Documented Adverse Effects
The evidence consistently identifies these concerns with hydroxyzine, but sodium disturbances are notably absent:
Cardiac effects: Hydroxyzine can cause QT prolongation and carries conditional risk for torsade de pointes, particularly in patients with underlying cardiovascular disease or concurrent QT-prolonging medications 4.
Sedation and cognitive impairment: First-generation antihistamines like hydroxyzine cause significant sedation, performance impairment, and cognitive decline, especially in elderly patients 5. These effects persist even with bedtime-only dosing due to prolonged half-life (approximately 20 hours) 6.
Anticholinergic effects: These can be problematic in elderly patients and those with narrow-angle glaucoma, benign prostatic hypertrophy, or cognitive impairment 5.
Dose Adjustments in Renal/Hepatic Disease
The guidelines specify that hydroxyzine dosing should be halved in moderate renal impairment and avoided in severe liver disease due to inappropriate sedating effects, not because of electrolyte concerns 2.
Clinical Pitfalls to Avoid
Do not confuse hydroxyzine with medications that actually affect sodium:
- Diuretics (thiazides, loop diuretics) cause hyponatremia through sodium loss
- SSRIs can cause SIADH and hyponatremia
- ACE inhibitors and ARBs affect potassium, not sodium primarily
Laboratory interference: Hydroxyzine and its metabolite cetirizine can cause false-positive results in carbamazepine immunoassays 7 and tricyclic antidepressant assays 8, but this is an analytical interference, not a true electrolyte disturbance.
Bottom Line for Practice
If you encounter hyponatremia in a patient taking hydroxyzine, look elsewhere for the cause. Common culprits include:
- Concurrent diuretic therapy
- Volume depletion or SIADH
- Other medications (SSRIs, carbamazepine, NSAIDs)
- Underlying medical conditions (heart failure, cirrhosis, renal disease)
Monitor hydroxyzine patients for sedation, anticholinergic effects, and cardiac conduction abnormalities—not sodium levels. Routine sodium monitoring is not indicated solely because a patient is taking hydroxyzine.